| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Aquilo Capital Management, LLC is a 10% Owner at PVLA with holdings across 2 companies. Recent SEC Form 4 filings include 15 buys and 5 sells.
Estimated insider holdings value: $454.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2021 | SPRO Spero Therapeutics, Inc. | 10% Owner | Buy | 250,493 | $15.42 | $3,862,897.82 | +1.7% | -45.7% | -89.2% | |
| Oct 29, 2021 | SPRO Spero Therapeutics, Inc. | 10% Owner | Buy | 150,000 | $17.53 | $2,630,175.00 | +3.3% | -35.1% | -88.8% | |
| Sep 30, 2021 | SPRO Spero Therapeutics, Inc. | 10% Owner | Buy | 134,543 | $18.65 | $2,509,173.13 | +3.0% | -17.2% | -89.1% | |
| Sep 14, 2021 | SPRO Spero Therapeutics, Inc. | 10% Owner | Buy | 46,366 | $18.56 | $860,547.07 | +0.5% | -26.4% | -95.0% | |
| Sep 9, 2021 | SPRO Spero Therapeutics, Inc. | 10% Owner | Buy | 24,749 | $18.50 | $457,792.15 | +0.6% | -24.1% | -93.9% | |
| Aug 31, 2021 | SPRO Spero Therapeutics, Inc. | 10% Owner | Buy | 92,687 | $18.42 | $1,707,518.91 | +1.1% | -25.1% | -95.8% | |
| Aug 27, 2021 | SPRO Spero Therapeutics, Inc. | 10% Owner | Buy | 36,939 | $16.67 | $615,853.58 | +0.4% | -10.9% | -94.7% | |
| Aug 24, 2021 | SPRO Spero Therapeutics, Inc. | 10% Owner | Buy | 399,195 | $15.51 | $6,192,042.14 | +3.3% | -0.7% | -94.2% | |
| Feb 8, 2021 | SPRO Spero Therapeutics, Inc. | 10% Owner | Sell | 3,000 | $21.74 | $65,215.20 | - | - | - | |
| Feb 4, 2021 | SPRO Spero Therapeutics, Inc. | 10% Owner | Sell | 100,000 | $19.02 | $1,901,987.34 | -0.6% | - | - |